Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-16-115635)

Filing Details

Accession Number:: 0001209191-16-115635
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-04-26 12:08:05
Reporting Period:: 2015-02-04

Filing Date:: 2016-04-26
Accepted Time:: 2016-04-26 12:08:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1337553	Aerie Pharmaceuticals Inc	AERI	Biological Products, (No Disgnostic Substances) (2836)	203109565

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1589991	D. Gerald Cagle	C/O Aerie Pharmaceuticals, Inc., 2030 Main Street, Suite 1500 Irvine CA 92614		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-02-04	500	$25.60	4,054	No	4	P	Direct
Common Stock	Acquisiton	2015-02-05	500	$24.54	4,554	No	4	P	Direct
Common Stock	Acquisiton	2015-08-10	100	$16.31	4,654	No	4	P	Direct
Common Stock	Acquisiton	2015-08-10	100	$16.35	4,754	No	4	P	Direct
Common Stock	Acquisiton	2015-08-10	100	$16.35	4,854	No	4	P	Direct
Common Stock	Acquisiton	2015-08-10	846	$16.39	5,700	No	4	P	Direct
Common Stock	Acquisiton	2015-08-12	500	$15.46	6,200	No	4	P	Direct
Common Stock	Acquisiton	2015-08-28	1,524	$16.60	7,724	No	4	P	Direct
Common Stock	Acquisiton	2015-08-28	476	$16.60	8,200	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct